Menna Fouda: What Should Oncologists Know About mRNA Cancer Vaccines?
Menna Fouda: What Should Oncologists Know About mRNA Cancer Vaccines? Oncodaily
Menna Fouda: What Should Oncologists Know About mRNA Cancer Vaccines? Oncodaily
New lung cancer drug adds nearly six months of survival stomach cancer treatment doubles it Ynetnews
This pancreatic cancer drug may extend lives — if patients can afford it | CBC News CBC
Препарат GSK устранил опухоли у 76% пациентов с раком прямой кишки Investing.com
Webinar on Including Older Adults in Cancer Research Now Available On Demand – SIOG Oncodaily
An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis published in CANCER indicates a shift toward surveillance in response to concerns of overdiagnosis and overtreatment that have hindered screening in the recent past.
Microbiotica Presents Phase 1b Clinical Data on MB097 at the European Society for Medical Oncology (ESMO) Congress 2026 WBOC TV
Immunotherapy combo extends survival for patients with aggressive small cell lung cancer, based on trial results presented by Dana-Farber at ESMO Congress 2026 | Newswise Newswise
AstraZeneca's Experimental Stomach Cancer Drug Doubles Survival In Trial NDTV
Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer BioSpace
Tennessee Oncology Researchers Help Lead Global Trial of Next-Generation Lung Cancer Therapy BioSpace
Пенсионерке из Челябинска удалили проросшую из шеи в грудь опухоль 360.ru
Aus oncologists elected to prestigious fellowship the limbic
Завершены испытания мРНК-вакцины от рака Телеканал «Наука
Новости медицины от 25 октября: заболеваемость колоректальным раком растет, и многие люди упускают возможности лечения из-за поздней диагностики. Vietnam.vn